ISCO — International Stem Cell Balance Sheet
0.000.00%
- $0.58m
- $2.69m
- $7.79m
- 53
- 65
- 13
- 39
Annual balance sheet for International Stem Cell, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.484 | 0.689 | 0.171 | 0.742 | 1.59 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.51 | 0.403 | 0.844 | 0.747 | 0.574 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 3.45 | 2.18 | 2.33 | 2.96 | 3.52 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.39 | 1.41 | 1.25 | 0.975 | 0.772 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 6.62 | 5.29 | 4.95 | 5.13 | 5.39 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.91 | 1.48 | 4.28 | 4.63 | 4.83 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 5.21 | 5.32 | 5.23 | 5.36 | 5.28 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1.41 | -0.033 | -0.288 | -0.22 | 0.113 |
Total Liabilities & Shareholders' Equity | 6.62 | 5.29 | 4.95 | 5.13 | 5.39 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |